People are averse to taking drugs

Many people are averse to taking drugs unless absolutely necessary and would prefer lifestyle change to medication, according a study in this week's BMJ.

Researchers in Liverpool interviewed a small group of family doctors, nurses, and lay people to explore their views on the minimum benefit they thought would justify drug treatment to prevent heart attacks.

Participants varied widely in the minimum acceptable benefits chosen. Many disliked the concept of taking pills every day and preferred lifestyle change to medication.

Participants wished to consider adverse effects and costs of treatment. They also wanted to make decisions for themselves, and clinicians supported this.

There is a danger that increased pressure on general practitioners to prescribe some drugs may distort practice and marginalise patients' preferences, say the authors. They believe that guidelines should reflect the importance of true dialogue between clinicians and patients before embarking on lifelong preventive treatment.

True dialogue between patient and doctor is essential, and patients' preference and values must be respected, adds Robert Johnstone in an accompanying commentary. He recommends that greater emphasis be placed on listening skills in doctor training and that more opportunities for "expert patient" training be provided.


Contact: Emma Dickinson
BMJ-British Medical Journal

Page: 1

Related medicine news :

1. People wounded in tsunami at risk of undetected fungal infections
2. People on food stamps cant afford heart-healthy meals
3. People are of two minds on moral judgments
4. People with low incomes more likely to develop brain tumors
5. People with chronic eye diseases not getting recommended eye exams
6. People with large pupils can now get LASIK and avoid night vision disturbances
7. People only slightly more likely to die after episodes of stagnant air
8. People with food allergies should not only be careful about what they eat
9. People who give, live longer: U-M study shows
10. People near freeways are exposed to 30 times the concentration of dangerous particles
11. People who dont dip have higher levels of clot factor and risk

Post Your Comments:

(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology:
Cached News: